Vascular anomalies in Alagille syndrome - A significant cause of morbidity and mortality

被引:231
作者
Kamath, BM
Spinner, NB
Emerick, KM
Chudley, AE
Booth, C
Piccoli, DA
Krantz, ID
机构
[1] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[4] Northwestern Univ, Sch Med, Childrens Mem Hosp, Div Gastroenterol & Nutr, Chicago, IL USA
[5] Childrens Hosp, Winnipeg, MB R3A 1S1, Canada
[6] Univ Manitoba, Winnipeg, MB, Canada
[7] Lutheran Gen Childrens Hosp, Park Ridge, IL USA
关键词
aneurysm; angiogenesis; cerebrovascular disorders; vasculature;
D O I
10.1161/01.CIR.0000121361.01862.A4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background - Alagille syndrome (AGS) is a dominantly inherited multisystem disorder involving the liver, heart, eyes, face, and skeleton, caused by mutations in Jagged1. Intracranial bleeding is a recognized complication and cause of mortality in AGS. There are multiple case reports of intracranial vessel abnormalities and other vascular anomalies in AGS. The objective of this study was to characterize the nature and spectrum of vascular anomalies in AGS. Methods and Results - Retrospective chart review of 268 individuals with AGS was performed. Twenty-five patients (9%) had noncardiac vascular anomalies or events. Sixteen patients had documented structural vascular abnormalities. Two had basilar artery aneurysms, 7 had internal carotid artery anomalies, and another had a middle cerebral artery aneurysm. Moyamoya disease was described in 1 patient. Three of the 16 patients had aortic aneurysms, and 2 had aortic coarctations. One of the patients with a basilar artery aneurysm also had coarctation of the aorta. One of the individuals with an internal carotid artery anomaly also had renal artery stenosis. Nine more patients had intracranial events without documented vessel abnormalities. Vascular accidents accounted for 34% of the mortality in this cohort. Conclusions - The vascular anomalies described in our cohort of AGS individuals identify an underrecognized and potentially devastating complication of this disorder. It is a major cause of morbidity and mortality in this population, accounting for 34% of the mortality. We have also reviewed the body of evidence supporting a role for Jagged1 and the Notch signaling pathway in vascular development.
引用
收藏
页码:1354 / 1358
页数:5
相关论文
共 29 条
[1]
SYNDROMIC PAUCITY OF INTERLOBULAR BILE-DUCTS (ALAGILLE SYNDROME OR ARTERIOHEPATIC DYSPLASIA) - REVIEW OF 80 CASES [J].
ALAGILLE, D ;
ESTRADA, A ;
HADCHOUEL, M ;
GAUTIER, M ;
ODIEVRE, M ;
DOMMERGUES, JP .
JOURNAL OF PEDIATRICS, 1987, 110 (02) :195-200
[2]
Renovascular hypertension and vascular anomalies in Alagille syndrome [J].
Bérard, E ;
Sarles, J ;
Triolo, V ;
Gagnadoux, MF ;
Wernert, F ;
Hadchouel, M ;
Niaudet, P .
PEDIATRIC NEPHROLOGY, 1998, 12 (02) :121-124
[3]
Bérard E, 2000, J PEDIATR-US, V136, P708
[4]
Alagille syndrome with angiographic associated moyamoya [J].
Connor, SEJ ;
Hewes, D ;
Ball, C ;
Jarosz, JM .
CHILDS NERVOUS SYSTEM, 2002, 18 (3-4) :186-190
[5]
Features of Alagille syndrome in 92 patients: Frequency and relation to prognosis [J].
Emerick, KM ;
Rand, EB ;
Goldmuntz, E ;
Krantz, ID ;
Spinner, NB ;
Piccoli, DA .
HEPATOLOGY, 1999, 29 (03) :822-829
[6]
OUTCOME OF SYNDROMIC PAUCITY OF INTERLOBULAR BILE-DUCTS (ALAGILLE SYNDROME) WITH ONSET OF CHOLESTASIS IN INFANCY [J].
HOFFENBERG, EJ ;
NARKEWICZ, MR ;
SONDHEIMER, JM ;
SMITH, DJ ;
SILVERMAN, A ;
SOKOL, RJ .
JOURNAL OF PEDIATRICS, 1995, 127 (02) :220-224
[7]
JAGGED1 expression in human embryos:: correlation with the Alagille syndrome phenotype [J].
Jones, EA ;
Clement-Jones, M ;
Wilson, DI .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) :658-662
[8]
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia [J].
Joutel, A ;
Corpechot, C ;
Ducros, A ;
Vahedi, K ;
Chabriat, H ;
Mouton, P ;
Alamowitch, S ;
Domenga, V ;
Cecillion, M ;
Marechal, E ;
Maciazek, J ;
Vayssiere, C ;
Cruaud, C ;
Cabanis, EA ;
Ruchoux, MM ;
Weissenbach, J ;
Bach, JF ;
Bousser, MG ;
TournierLasserve, E .
NATURE, 1996, 383 (6602) :707-710
[9]
Krebs LT, 2000, GENE DEV, V14, P1343
[10]
LABRECQUE DR, 1982, HEPATOLOGY, V2, P467